Thymopentin in the treatment of herpes zoster

M. Lomuto, P. Zenarola, G. Ditano, N. Cascavilla

Research output: Contribution to journalArticlepeer-review


The authors proposed the use of thymopentin, a new immunomodulating drug, for the treatment of herpes zoster. The observations in 53 subjects treated with thymopentin and 90 patients treated with traditional therapy highlighted the ability of the drug to reduce the duration of the disease and scabbing time. The early start of therapy produced a notable reduction of the pain characteristic of herpes zoster. On the basis of their observations, the authors assumed that thymopentin possesses an antiphlogistic activity.

Original languageEnglish
Pages (from-to)672-678
Number of pages7
JournalCurrent Therapeutic Research
Issue number4
Publication statusPublished - 1988

ASJC Scopus subject areas

  • Medicine(all)


Dive into the research topics of 'Thymopentin in the treatment of herpes zoster'. Together they form a unique fingerprint.

Cite this